Of the 10 most populous U.S. metros, Philadelphia has a larger share of jobs classified as highly vulnerable to AI disruption than all but one. The region's female workers face the biggest risk.

MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced the publication of the analytical validation ...

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to ...

The venue is expected to support more than 7,000 jobs and draw over 2 million visitors annually by 2032, the report estimates ...

In the U.S., about 7,000 people live with hereditary angioedema, or HAE,1,2 a rare condition that results in unpredictable swelling attacks.3-8 Symptoms often appear early in life and ...